IDT CORP (IDT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 07-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q4 '21: 390M Q1 '22: 370.1M Q2 '22: 337.1M Q3 '22: 328.4M Q4 '22: 328.6M Q1 '23: 321.8M Q2 '23: 313.9M Q3 '23: 299.3M Q4 '23: 303.8M Q1 '24: 301.2M Q2 '24: 296.1M Q3 '24: 299.6M Q4 '24: 308.8M Q1 '25: 309.6M Q2 '25: 303.3M Q3 '25: 302M Q4 '25: 316.6M Q1 '26: 322.8M Q2 '26: 320.5M Q3 '26: 315.7M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

0 50M 100M 150M Q2 '12: 59.1M Q3 '12: 59.9M Q4 '12: 60.9M Q1 '13: 65.3M Q2 '13: 67.2M Q1 '23: 89.1M Q2 '23: 90.4M Q3 '23: 87.6M Q4 '23: 90.7M Q1 '24: 94M Q2 '24: 96.9M Q3 '24: 97M Q4 '24: 102.2M Q1 '25: 107.6M Q2 '25: 112.1M Q3 '25: 112M Q4 '25: 114.5M Q1 '26: 118.2M Q2 '26: 121.3M Q3 '26: 122.5M Q3 '12 Q2 '13 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Income Quarterly

0 15M 30M 45M Q4 '21: 16.9M Q1 '22: 13.8M Q2 '22: 13.8M Q3 '22: 13.3M Q4 '22: 19.2M Q1 '23: 20.2M Q2 '23: 18.2M Q3 '23: 10.4M Q4 '23: 12M Q1 '24: 17.2M Q2 '24: 16M Q3 '24: 11.4M Q4 '24: 20.1M Q1 '25: 23.6M Q2 '25: 28.3M Q3 '25: 26.6M Q4 '25: 21.9M Q1 '26: 30.9M Q2 '26: 27.2M Q3 '26: 29.8M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income Quarterly

-15M 0 15M 30M 45M Q4 '21: 38.7M Q1 '22: -2.5M Q2 '22: 7.5M Q3 '22: 4.8M Q4 '22: 17.2M Q1 '23: 11M Q2 '23: 14.6M Q3 '23: 6.9M Q4 '23: 8M Q1 '24: 7.7M Q2 '24: 14.4M Q3 '24: 5.6M Q4 '24: 36.8M Q1 '25: 17.2M Q2 '25: 20.3M Q3 '25: 21.7M Q4 '25: 16.9M Q1 '26: 22.4M Q2 '26: 20.9M Q3 '26: 21.6M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q3 '18: 307.2M Q4 '18: 325.1M Q1 '19: 304.7M Q2 '19: 291.2M Q3 '19: 282.8M Q1 '23: 232.7M Q2 '23: 223.5M Q3 '23: 211.7M Q4 '23: 213.1M Q1 '24: 207.2M Q2 '24: 199.2M Q3 '24: 202.6M Q4 '24: 206.6M Q1 '25: 201.9M Q2 '25: 191.2M Q3 '25: 190M Q4 '25: 202.1M Q1 '26: 204.6M Q2 '26: 199.2M Q3 '26: 193.2M Q4 '18 Q3 '19 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Cash Flow Quarterly

-30M 0 30M 60M 90M Q4 '21: 28.5M Q1 '22: -5.9M Q2 '22: 17.5M Q3 '22: 1.6M Q4 '22: 16.1M Q1 '23: 18.2M Q2 '23: 17.4M Q3 '23: -6.9M Q4 '23: 23.7M Q1 '24: 14.9M Q2 '24: 28.4M Q3 '24: 9.5M Q4 '24: 25.4M Q1 '25: 164K Q2 '25: 20.2M Q3 '25: 75.7M Q4 '25: 31M Q1 '26: -10.1M Q2 '26: 38.3M Q3 '26: 18.5M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

-25M 0 25M 50M 75M Q4 '21: 25.2M Q1 '22: -10.2M Q2 '22: 12.9M Q3 '22: -3.2M Q4 '22: 8.1M Q1 '23: 13M Q2 '23: 12M Q3 '23: -12.4M Q4 '23: 17.8M Q1 '24: 10.6M Q2 '24: 23.9M Q3 '24: 4.7M Q4 '24: 20.1M Q1 '25: -5.1M Q2 '25: 15.3M Q3 '25: 70.3M Q4 '25: 25.7M Q1 '26: -16M Q2 '26: 32.2M Q3 '26: 13.4M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 10M 20M 30M Q2 '20: 26.5M Q3 '20: 26.5M Q1 '21: 25.9M Q2 '21: 25.7M Q3 '21: 26.1M Q1 '22: 25.6M Q2 '22: 26.5M Q3 '22: 26.2M Q1 '23: 25.6M Q2 '23: 25.5M Q3 '23: 25.6M Q1 '24: 25.3M Q2 '24: 25.3M Q3 '24: 25.5M Q1 '25: 25.4M Q2 '25: 25.3M Q3 '25: 25.2M Q1 '26: 25.2M Q2 '26: 25.1M Q3 '26: 24.9M Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '21: 3.69 Q1 '22: 3.27 Q2 '22: 3.04 Q3 '22: 1.83 Q4 '22: 1.02 Q1 '23: 1.55 Q2 '23: 1.84 Q3 '23: 1.93 Q4 '23: 1.58 Q1 '24: 1.45 Q2 '24: 1.45 Q3 '24: 1.40 Q4 '24: 2.54 Q1 '25: 2.92 Q2 '25: 3.15 Q3 '25: 3.79 Q4 '25: 3.01 Q1 '26: 3.22 Q2 '26: 3.26 Q3 '26: 3.27 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.